Medicines List

Description

Sodium chloride is the main salt for maintaining plasma and isotonicity of other tissues, thus affecting the water and electrolyte balance. In patients who do not have dehydration, excess sodium chloride leads to a salt diuretic effect, while in the presence of dehydration, it acts as a source of water and electrolytes.

Indications

Sodium chloride-Tchaikapharma is used for the following indications:
– Dissolution of powdered dosage forms for injection;
– Dilution of concentrated solutions for injection;
– Flushing and replenishment of intravenous catheters and cannulas for temporary access.

Subject to medical prescription.

Concentration and pharmaceutical form: 0.9 % solution for injection

Description

Sinepar is a medicine that combines the aromatic amino acid carbidopa monohydrate (a decarboxylase inhibitor) with levodopa (a metabolic precursor of dopamine) in a prolonged-release tablet.

Indications

Sinepar is used to treat the symptoms of Parkinson’s disease.
Parkinson’s disease is a chronic disease characterized by delayed and unstable movements, muscle stiffness and tremor. If left untreated, Parkinson’s disease can make your daily routine difficult.

Subject to medical prescription.

Concentration and pharmaceutical form: 200 mg/50 mg prolonged-release tablets

Description

Isosorbe contains isosorbide mononitrate, which belongs to a group of medicines called organic nitrates. Isosorbide mononitrate works by widening arteries that supply blood and oxygen to the heart and reduces the risk of angina (chest pain), which occurs when the blood supply to the muscles of the heart is restricted.

Indications

Prophylactic and long-term treatment of angina pectoris.

Subject to medical prescription.

Concentration and pharmaceutical form: 40 mg prolonged-release tablets

Description

Apiri is a medicine that contains acetylsalicylic acid. Taken in high doses, it relieves pain and reduces inflammation, lowers fever. Apiri at lower doses reduces the ability of blood platelets (thrombus) to adhere both to one another and to the walls of blood vessels, which reduces the risk of blood clots (thrombus).

Indications

Apiri is indicated for use in the following cardiovascular conditions:
– to reduce the risk of mortality in patients with suspected acute myocardial infarction;
– to reduce the risk of mortality in patients with myocardial infarction;
– for secondary prevention of stroke;
– to reduce the risk of transient ischemic attacks (TIA) and stroke in patients with TIA;
– to reduce the risk of morbidity and mortality in patients with stable and unstable angina;
– for the prevention of thromboembolism after vascular surgery or other interventions e.g. PTCA, CABG, carotid endarterectomy, arteriovenous shunts;
– for the prevention of deep vein thrombosis and pulmonary embolism after prolonged immobilization, e.g. after major surgery;
– to reduce the risk of primary myocardial infarction in individuals at cardiovascular risk, such as diabetes mellitus, hyperlipidemia, arterial hypertension, obesity, smoking and in elderly people.

Subject to medical prescription.

Concentration and pharmaceutical form: 100 mg gastro-resistant tablets